BioCentury
ARTICLE | Clinical News

Allob: Phase I/IIa started

July 14, 2014 7:00 AM UTC

Bone Therapeutics began an open-label, European Phase I/IIa trial to evaluate a single implantation of Allob in 32 patients with non-infected, delayed-union fractures of long bones. A delayed-union fr...